Whole blood survival motor neuron protein levels correlate with severity of denervation in spinal muscular atrophy

Muscle & Nerve
Christiano R R AlvesKathryn J Swoboda

Abstract

We sought to determine whether survival motor neuron (SMN) protein blood levels correlate with denervation and SMN2 copies in spinal muscular atrophy (SMA). Using a mixed-effect model, we tested associations between SMN levels, compound muscle action potential (CMAP), and SMN2 copies in a cohort of 74 patients with SMA. We analyzed a subset of 19 of these patients plus four additional patients who had been treated with received gene therapy to examine SMN trajectories early in life. Patients with SMA who had lower CMAP values had lower circulating SMN levels (P = .04). Survival motor neuron protein levels were different between patients with two and three SMN2 copies (P < .0001) and between symptomatic and presymptomatic patients (P < .0001), with the highest levels after birth and progressive decline over the first 3 years. Neither nusinersen nor gene therapy clearly altered SMN levels. These data provide evidence that whole blood SMN levels correlate with SMN2 copy number and severity of denervation.

References

Feb 13, 2002·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Matthew D MailmanThomas W Prior
Sep 1, 2009·American Journal of Human Genetics·Thomas W PriorJohn T Kissel
May 5, 2012·PloS One·Thomas O CrawfordUNKNOWN Pilot Study of Biomarkers for Spinal Muscular Atrophy Trial Group
May 5, 2012·PloS One·Richard S FinkelUNKNOWN Pilot Study of Biomarkers for Spinal Muscular Atrophy Trial Group
Oct 30, 2014·The New England Journal of Medicine·Kathryn J Swoboda
Jun 27, 2015·Journal of Marriage and the Family·Rebekah Young, David R Johnson
Nov 2, 2017·The New England Journal of Medicine·Jerry R MendellBrian K Kaspar
May 30, 2019·Annals of Clinical and Translational Neurology·Basil T DarrasCharlotte J Sumner
Sep 14, 2019·Neurology. Genetics·Flávia C NeryKathryn J Swoboda
Oct 8, 2019·The Journal of Clinical Investigation·Daniel M RamosCharlotte J Sumner
Dec 29, 2019·Neurology·Christiano R R AlvesKathryn J Swoboda

❮ Previous
Next ❯

Citations

Jul 23, 2020·Muscle & Nerve·Arlene D'Silva, Michelle A Farrar
Apr 2, 2021·Annals of Clinical and Translational Neurology·Maren FreigangRené Günther
May 16, 2021·Annals of Clinical and Translational Neurology·Eric J EichelbergerKathryn J Swoboda
Apr 2, 2021·Clinical Pharmacology and Therapeutics·Giovanni BaranelloLaurent Servais
Aug 24, 2021·Biomarker Insights·Megan G PinoStephen J Kolb

❮ Previous
Next ❯

Methods Mentioned

BETA
SMA
antisense oligonucleotide

Clinical Trials Mentioned

NCT02386553
NCT03505099

Software Mentioned

PharmOptima
SAS

Related Concepts

Related Feeds

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.